Investigating how poverty alleviation policies affect the risk of Alzheimer's disease and related dementias.
Official title: Bridging Social Epidemiology and Policy for ADRD Prevention: Effects of Poverty Alleviation Policies on Alzheimer's Disease and Related Dementias Risk and Disparities
Funded at Boston University Medical Campus · NIH-11135997 · Data updated 2026-11-12
This study looks at how programs designed to help people in poverty might affect the chances of developing Alzheimer's disease and related conditions, and it's for anyone interested in understanding how social support can improve health for those at risk.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | May 1, 2025 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $131,813 |
| NIH project number | 1K99AG088369-01A1 |
| Project ID | NIH-11135997 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for Alzheimer's disease and related dementias, particularly those from low-income backgrounds or affected by poverty.
✕Less likely to help
Patients who are not at risk for Alzheimer's disease or related dementias, or those who do not experience the effects of poverty, may not benefit from this research.
What this research studies
This research explores the relationship between poverty alleviation policies and the risk of Alzheimer's disease and related dementias (AD/ADRD). By analyzing data from the Health and Retirement Study and Medicare records, the project aims to quantify how these policies impact AD/ADRD prevalence across different states and demographic groups. The research will utilize quasi-experimental methods to evaluate the effectiveness of various social policies in reducing health disparities associated with AD/ADRD. Ultimately, the goal is to provide insights that could inform future policy decisions aimed at improving health outcomes for vulnerable populations.
Why it matters
Potential benefit: If successful, this research could lead to more effective policies that reduce the risk of Alzheimer's disease and related dementias, particularly among disadvantaged groups.
How similar studies have gone: Previous research has indicated that social policies can significantly impact health outcomes, suggesting that this approach has the potential for success.
Where this research is happening
-
Boston University Medical Campus
Boston, United States Active
Researchers
- Principal investigator: Chen, Ruijia — Boston University Medical Campus
- Study coordinator: Chen, Ruijia
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.